Should we perform baseline NGS testing in precursor T lymphoblastic leukaemias: a single centre experience from Eastern India
Molecular profiling of TALLs do not significantly impact long-term survival outcomes. In resource-constrained settings, we can get away by not doing comprehensive molecular profiling of TALLs at baseline and restrict the sequencing assay to only those cases that are persistently MRD positive or have relapsed.
Authors
- Anil Kumar Singh (ORCID: https://orcid.org/0000-0001-7177-5901)
- Vikramjit S. Kanwar (ORCID: https://orcid.org/0000-0001-6054-1579)
- Pradeep Arumugam
- Raghwesh Ranjan
- Prateek Das
- Nilesh Dhole
- Anil Kumar Yadav (ORCID: https://orcid.org/0000-0001-9784-5242)
- Sunil Kumar (ORCID: https://orcid.org/0000-0003-2558-6717)
- Neha Singh (ORCID: https://orcid.org/0000-0003-0773-865X)
- Rohit Kumar Kori
Institutions
- Homi Bhabha National Institute (IN)
Publication Details
- Journal
- ecancermedicalscience
- Published
- 2024-12-06
- DOI
- https://doi.org/10.3332/ecancer.2024.1815
- Citations
- 1
- Primary Topic
- Acute Lymphoblastic Leukemia research
- Type
- article
- Field-Weighted Citation Impact
- 0.54